Overview
DIA and the Duke-NUS Centre of Regulatory Excellence (CoRE) will host a 2-day conference in Singapore on accelerating access to health products to improve the response to pandemic diseases. Over these 2 days, we will discuss the global impact of infectious diseases and approaches to expedite research and product development (including vaccines and medical devices). We will also explore the pathways to accelerate patient access to innovative products and how to effectively manage a pandemic situation in Asia. Speakers will include experts from Health Authorities, NGOs, as well as the industry and academia.
Download the Exhibitor/Sponsorship Prospectus
Just in!
Dorothee Grimald, PharmD, Director of Global Regulatory Policy for MSD International in Singapore, and Chair for this conference, discusses ways to expedite patient access to combatic therapies in a late-breaking interview. Listen now!
Who should attend?
- Industry professionals involved in Research & Development, Regulatory Affairs and Medical Affairs in Pharmaceuticals and Medical Technology
- Regulators and personnel from Health Authorities and Ministries
- Academia and Researchers
Program Committee
-
Dorothee Grimald, PharmD • Director, Global Regulatory Policy
Merck Sharp and Dohme USA, United States -
James Leong, PhD, MPharm • Head of Pharmaceutical Regulatory Science Programme
Duke NUS, Singapore -
Esther Siu-Suet Chu, MBA • Head/ Executive Director, Drug Development Operations (APAC)
Allergan Singapore Pte Ltd, Singapore -
Jui-Fen Liu, MSc, RPh • APAC Regional Regulatory Policy Lead
Roche Singapore Pte Ltd, Singapore -
Michelle Cheng, RPh, RAC • Head of Regulatory Affairs, Singapore & Asian Emerging Markets
Novartis Singapore Pte Ltd, Singapore -
Thean Soo Lo •
Regulatory Affairs Management Consultant, Singapore -
Silke Vogel, PhD • Deputy Director, Center of Regulatory Excellence (CoRE); Associate Dean
Duke NUS , Singapore -
Shun Jin, MBA • Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore -
Jing Ping Yeo, PhD • Director, Research Integrity, Compliance and Ethics
Singhealth, Singapore -
Kum Cheun Wong, PharmD • Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Stephanie Danandjaja • APAC Medical Director
Abbott EPD, Singapore -
Vicky (Fengyun) Han • Senior Director, Asia Pacific Regulatory Policy Group Lead, Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore
